Clozapine, a dibenzodiazepine, is weak antagonistic to D2 receptors and has significant activity against dopamine D4 and 5-HT2 receptors, particularly in the treatment of PD at a low dose [114, 115]. Here, HTR2A is linked to Parkinson disease.